You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

epirubicin

Showing 1 - 25 of 173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Epirubicin
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial (Toripalimab, Epirubicin, High Intensity Focused Ultrasoun)

Not yet recruiting
  • Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
Aug 5, 2022

Soft Tissue Sarcoma Trial in Beijing, Shanghai (Anlotinib HCl capsule, Epirubicin, Arotinib HCl capsule )

Recruiting
  • Soft Tissue Sarcoma
  • Anlotinib hydrochloride capsule
  • +2 more
  • Beijing, Beijing, China
  • +2 more
Feb 16, 2022

Sepsis Trial in Germany (Epirubicin, Placebo)

Not yet recruiting
  • Sepsis
  • Epirubicin
  • Placebo
  • Jena, Thuringia, Germany
  • +4 more
Feb 25, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Breast Cancer, Neoadjuvant Therapy Trial in Beijing (Utidelone, Carboplatin, Epirubicin)

Not yet recruiting
  • Breast Cancer
  • Neoadjuvant Therapy
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Aug 1, 2023

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Bladder Cancer, Non-muscle Invasive Trial in Biel (Epirubicin, Mitomycin, Gemcitabine)

Recruiting
  • Bladder Cancer
  • Non-muscle Invasive
  • Epirubicin
  • +3 more
  • Biel, Switzerland
    Roland Seiler
Nov 17, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Idarubicin Hydrochloride for Injection, Epirubicin)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Idarubicin Hydrochloride for Injection
  • Epirubicin
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Breast Cancer Trial (Gemcitabine, Epirubicin, Docetaxel)

Completed
Has Results
  • Breast Cancer
  • (no location specified)
Oct 4, 2021

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

Hepatocellular Carcinoma Trial in Nanjing (cTACE, Dicycloplatin (TP21), Epirubicin)

Recruiting
  • Hepatocellular Carcinoma
  • cTACE
  • +2 more
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Jul 22, 2022

Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

Enrolling by invitation
  • Peripheral T-cell Lymphoma Targeted Therapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023

Breast Cancer Trial in Beijing (Pembrolizumab, Paclitaxel, Epirubicin)

Recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Dec 28, 2022